Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» If Approved -- FDA Drug Labeling Could Decide Ultimate Success of MannKind's Afrezza
If Approved -- FDA Drug Labeling Could Decide Ultimate Success of MannKind's Afrezza
If Approved -- FDA Drug Labeling Could Decide Ultimate Success of MannKind's Afrezza
Submitted by
admin
on January 20, 2010 - 9:13am
Source:
BNET Pharma
News Tags:
MannKind
Afrezza
inhaled insulin
diabetes
Headline:
If Approved -- FDA Drug Labeling Could Decide Ultimate Success of MannKind's Afrezza
Do Not Allow Advertisers to Use My Personal information
